Navigation Links
MedImmune Announces Seven Key Promotions and New Hires
Date:11/5/2007

GAITHERSBURG, Md., Nov. 5 /PRNewswire/ -- MedImmune, Inc. today announced that it has made several new senior appointments across the organization. Alexander A. Zukiwski, M.D., senior vice president, clinical research; Timothy J. Hahn, Ph.D., vice president, antibody manufacturing; and Timothy J. Maines, vice president, corporate quality assurance have recently joined the company. In addition, new executive promotions include Max Donley, vice president, human resources; Jonathan Klein-Evans, J.D., vice president, intellectual property; Timothy Pearson, vice president & chief financial officer; and Paul Williams, vice president, sales operations.

"As MedImmune transitions into its new role as the global biologics unit of AstraZeneca, it is imperative to strengthen the company's leadership platform across all facets of our business. Alex, Tim Hahn and Tim Maines add an additional depth of expertise in the areas of clinical research, antibody manufacturing, and quality assurance, respectively, which are each critical to our ability to deliver new drugs to patients in need," said David M. Mott, chief executive officer and president. "The new vice presidential appointments of Max, Jonathan, Tim Pearson and Paul foster MedImmune's ability to continue to recruit and grow talent, protect our intellectual properties, manage our financial reporting obligations to AstraZeneca plc (our parent company) and serve our customers to the highest possible standards."

New Leadership

As the newest senior addition, Dr. Alexander Zukiwski joins MedImmune as senior vice president, clinical research, where he will be responsible for shaping and overseeing the company's strategy for clinical trials of its drug candidates. Prior to joining the company, Dr. Zukiwski held several roles of increasing responsibility in support of Johnson & Johnson's (J&J) medical affairs and clinical development functions at Johnson & Johnson Pharmaceutical Research & Development, LLC (J&
'/>"/>

SOURCE MedImmune, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. MedImmune Licenses Reverse Genetics Technology to Novartis for Use in Influenza Vaccine Development and Production
2. MedImmune Celebrates Opening of New Pilot Lab at Gaithersburg Headquarters
3. MedImmune Recognized by Local Volunteer Organization for Its Employees Exceptional Commitment to Community Service within Montgomery County
4. MedImmune to Present RSV Surveillance and Cost-Effectiveness Data at American Academy of Pediatrics National Conference & Exhibition
5. AstraZeneca Bolsters Its Worldwide Biologics Division Through Integration of Cambridge Antibody Technology Into MedImmune
6. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
7. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
8. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
9. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
10. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
11. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)...menopause to postmenopause , , MONTVALE, N....y and intensity of vasomotor symptoms is a challen...nt and The Journal of Family Practice have rece...toms: Managing the transition from perimenopause t...or, MD, CM and Lee P. Shulman, MD, discuss the ben...
(Date:12/2/2008)...Applied BioSciences has turned to MBI Internationa...cial viability of an important bio-based product l... gap between research and commercialization throug...es. MBI’s unique “Collaborative De-Ris...ological uncertainties, which impede new technolog...
(Date:12/2/2008)...wire/ -- GeneGo, Inc., the leading systems biology...ecome a certified GeneGo Center of Excellence. Bur... to GeneGo,s MetaCore data analysis suite, trainin...a world-class biomedical research facility running...ny departments, including research in cancer, stem...
(Date:12/2/2008)...wire/ -- Intradigm Corporation, a leading,develop...herapeutics, today,announced the issuance of Unit... Compositions for Controlling Efficacy of RNA Sile... seminal research of Philip Zamore, Ph.D., the,Gr... Professor of Biochemistry,& Molecular Pharma...
Breaking Biology Technology: DuPont Applied BioSciences Selects MBI to Collaborate on Process Development and Scale-Up for New Bio-based Product 2The Burnham Institute for Medical Research Becomes a GeneGo Center of Excellence Using MetaCore for Stem Cell Research and Neurology 2Intradigm Announces Issuance of Key Patent Related to Enhancing Efficacy and Potency of RNAi Therapeutics 2Intradigm Announces Issuance of Key Patent Related to Enhancing Efficacy and Potency of RNAi Therapeutics 3
... Wis. - This summer, venture investors deployed m...s Wisconsin, a total that may bode well for improv...ile it is difficult to draw firm conclusions from ...ld indicate that technologically innovative compan...ase of capital in 2006. , ,"With the growth of the...
... Wis. - The Madison-based National Stem Cell Ban...tem cells from the University of California-San F...available on the federal registry. , ,Beth Donley,...ute , which houses the stem cell bank, said the or...ave all 21 federally approved lines. , ,"We,re ver...
...Wis. - The Center for Advanced Technology and In...ogy-based economic development programs. , ,An awa...uncil recognizes CATI,s work in developing a $40 ...uch as Kraft Foods , S.C. Johnson , and Boeing ...ments, five company product line expansions, and t...
... Wis. - Genetically engineered mice are very expe...ny has developed a method for producing similarly ...io Corp. , a privately-held biopharmaceutical firm...urdles associated with producing modified mice at ... animals instead. , ,Mirus has begun using its spe...
Other Biology Technology:Summer venture investments total $18 million for Wisconsin start ups 2Summer venture investments total $18 million for Wisconsin start ups 3Summer venture investments total $18 million for Wisconsin start ups 4Nation's only stem cell bank will receive UC-San Francisco cell line 2Mirus provides low-cost way to modify genes 2
(Date:12/2/2008)...ywhere else in the world. This is having a major i...nvironment and effect of cities on rural areas. On...ca,s history is being over-looked. , Joy Clancy ...blem in the current issue of the African Journal ...the African population was rural, today 38% live i...
(Date:12/2/2008)...tion due to climate change, pollution and human ac... providing satellite data of the region for the la...ion with ESA,s future missions will be key in impl...icy called ,The European Union and the Arctic Regi...n the region such as the opening up of long-sought...
(Date:12/1/2008)...spread consumption advisories and uncertainty amon...w researchers at North Carolina State University h...d regulators around the country predict which area... a breakthrough that should help officials addres...es for specific water bodies and fish species. , ...
(Date:12/1/2008)...old a colloquium to examine what lies ahead in evo...isms. Leading researchers and students will discus...tion and even evolution from the perspectives of e...ity informatics dealing with microbes, plants, and...he event will take place at the Arnold and Mabel B...
Breaking Biology News(10 mins):ESA satellites focusing on the Arctic 2New model predicts hot spots for mercury in fish 2American Council on Exercise Offers 10 Tips for Surviving the Holidays 2847 1American Council on Exercise Offers 10 Tips for Surviving the Holidays 2847 2IDM Pharma to Present at BIO InvestorForum in San Francisco 1045 1IDM Pharma to Present at BIO InvestorForum in San Francisco 1045 2IDM Pharma to Present at BIO InvestorForum in San Francisco 1045 3Environmental Tectonics Corporations BioMedical Division Announces New Contract 1042 1Environmental Tectonics Corporations BioMedical Division Announces New Contract 1042 2Environmental Tectonics Corporations BioMedical Division Announces New Contract 1042 3Clarient Names Michael J Pellini M D Chief Operating Officer 2845 1Clarient Names Michael J Pellini M D Chief Operating Officer 2845 2Clarient Names Michael J Pellini M D Chief Operating Officer 2845 3Clarient Names Michael J Pellini M D Chief Operating Officer 2845 4
...wly identified gene expression profile could help ...will respond to chemotherapy treatment. Described ...urnal of Clinical Oncology (JCO), the new findings...y gene profiling as a predictor of clinical outcom...clinicians with insights into the mechanisms of dr...
... preliminary results from a study in Botswana, Har...d that people with HIV-1 subtype C in resource-poo...py, can achieve comparable results to those in the...livery system and infrastructure help ensure this ...005 issue of the Journal of Acquired Immune Defici...
...am of researchers led by scientists at Memorial Sl... new class of drugs -- now in early stage clinical... the BRAF gene. BRAF is a protein that plays a cen...ls and is mutated in the majority of patients with..., breast, and lung cancers. The findings, availabl...
...rding to research reported this week in Current Bi...e epicenter of the 2004 Sumatra-Andaman earthquake...mited, particularly when compared to damage from c...0 days after the tsunami of December 26, 2004, a t...Wildlife Conservation Society-Indonesia Program, a...
Other Biology News:Gene expression profile helps predict chemotherapy response in ovarian cancer patients 2Gene expression profile helps predict chemotherapy response in ovarian cancer patients 3New Therapeutic Target Identified In Inherited Brain Tumor Disorder 2Mutations in the BRAF gene predict sensitivity to a novel class of cancer drugs 2
Any form, any size, any number of mutageneses. ExonBio provides the best service with double sequecing to make sure the success of the mutagenesis.
Request Info
Makes gels easy to load and track during electrophoresis. 10X concentrate of Bromophenol Blue, glycerol solution.
Epi-Grids™ Colony Grid Templates are easy-to-use griding templates that allow rapid organization of colonies from initial screening plates and for preparing precise master plates.
Biology Products: